Accounts Receivables - NuVasive Inc (F:NK8) - Alpha Spread
N

NuVasive Inc
F:NK8

Watchlist Manager
NuVasive Inc
F:NK8
Watchlist
Price: 36.8 EUR Market Closed
Market Cap: 1.9B EUR
Have any thoughts about
NuVasive Inc?
Write Note

NuVasive Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

NuVasive Inc
Accounts Receivables Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
N
NuVasive Inc
F:NK8
Accounts Receivables
$267.1m
CAGR 3-Years
14%
CAGR 5-Years
6%
CAGR 10-Years
11%
Becton Dickinson and Co
NYSE:BDX
Accounts Receivables
$2.6B
CAGR 3-Years
8%
CAGR 5-Years
3%
CAGR 10-Years
8%
Boston Scientific Corp
NYSE:BSX
Accounts Receivables
$2.4B
CAGR 3-Years
13%
CAGR 5-Years
7%
CAGR 10-Years
6%
Stryker Corp
NYSE:SYK
Accounts Receivables
$3.6B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Accounts Receivables
$6.9B
CAGR 3-Years
4%
CAGR 5-Years
4%
CAGR 10-Years
5%
Intuitive Surgical Inc
NASDAQ:ISRG
Accounts Receivables
$1.1B
CAGR 3-Years
17%
CAGR 5-Years
12%
CAGR 10-Years
15%

See Also

What is NuVasive Inc's Accounts Receivables?
Accounts Receivables
267.1m USD

Based on the financial report for Jun 30, 2023, NuVasive Inc's Accounts Receivables amounts to 267.1m USD.

What is NuVasive Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
11%

Over the last year, the Accounts Receivables growth was 14%. The average annual Accounts Receivables growth rates for NuVasive Inc have been 14% over the past three years , 6% over the past five years , and 11% over the past ten years .

Back to Top